MSF's Suerie Moon spoke in front of a US Senate Committee on promoting new treatments & cures for neglected diseases read more
NEW: The 13th Edition of Untangling the Web of Antiretroviral Price Reductions is now available download it here
VIDEO: MSF's community approach to treating malnutrition in Niger watch it here
WHO's work on the financing of medical research and development is given a fresh start read more
MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
|
 |
|
 |
MSF's Statement regarding the 2010 Special 301 Review
Op-ed: G-20 Leaders Put Your Money Where the Needs Are
MSF EWG Intervention at 63rd World Health Assembly
WHA 2010: Counterfeit Medicinal Products
WHA 2010: Public Health, Innovation, and Intellectual Property
MSF's Letter to the WHA Delegates
MSF Statement on the Pipeline Case in Brazil
Are Brazilian Pipeline Patents Constitutional?
India: Will Pharma, trade agreements shut down the Pharmacy of the Developing World?
EC Trade Commissioner's Response to MSF Letter on India-EU FTA
Trading away the lives of people living with HIV/AIDS
MSF Letter to EC Trade Commissioner on EU-India FTA
DNP+ Reaction Statement to Indian Trade Minister
DNP+ Open Statement to EU Trade Commissioner on EU-India FTA
Thai Civil Society Statement on India Free Trade Agreements
You’re trading away our lives! Voices of people living with HIV rise up in protest in Delhi
DNP Letter to Members of Indian Parliament
MSF Letter to Indian PM Dr. Manmohan Singh
Victory for access to medicines as Bayer loses lawsuit in India
Heat-stable ritonavir approved
Profound Health Impact for Small Change
European Parliament Working Group
Lunch Debate: AIDS treatment gap widening in Sub-Saharan Africa: what does the European Union do?
Symposium: Innovate to Eliminate TB
Brown Bag Lunch: FTA & Transit Issues
New Working Group Launches at European Parliament with MSF support
MSF Intervention at 126th WHO EB on MDGs
Intervention at WHO: MSF concerned about report on R&D financing
Invitation for Inauguration of the European Parliament Working Group
Joint Declaration with HAI Europe and Oxfam: Trading Away Access to Medicines
The patent pool could deliver much needed new combination therapies
MSF workshop at WTO Public Forum
MSF response to India's rejection of patents on key HIV/AIDS drugs
Novartis attacks Indian patent law again threatening furture of access to affordable medicines
Put HIV/AIDS drugs in the patent pool!
AIDS Emergency is Far from Over
Audio: Thailand's experience with compulsory licensing
BBC interview on H1N1 flu vaccine access
Generics and access to influenza treatment
The U.S. FDA Priority Review Voucher
Letters to EC on Netherlands Customs Seizure
Ellen 't Hoen book: Global Politics of Pharmaceutical Monopoly Power
Taking the Plunge: Pooling Patents Could Help Get Urgently Needed New Medicines
Meet the Activist: Leena Menghaney
MSF Intervention at WHO Executive Board 2009
The Global Politics of Pharmaceutical Monopoly Power by Ellen ‘t Hoen
Counterfeit, Substandard and Generic Drugs
Valganciclovir Patent Set Aside in India
MSF Workshop at the WTO on August 30th
MSF statement on FDA warning to Ranbaxy
ABIA and SAHARA joint press release on patent opposition for tenofovir
DNP+ press release on valganciclovir pre-grant patent opposition
Tenofovir and Valganciclovir Patent Oppositions
Pre-grant opposition victory in India
Protecting the next generation: PMTCT programme in Madi Opei, Northern Uganda
MSF letter to The Global Fund on concerns over scale-up of AIDS treatment
MSF letter to Global Fund concerning replenishment in light of WHO guidelines
Untangling the Web of antiretroviral price reductions: 11th edition
Interview with Pharmaceutical Coordinator Elodie Jambert
UTW: Interview with Campaign pharmacist
MSF responds to World Health Organization’s new HIV treatment guidelines
Global Fund Board Commits to New Funding Round
MSF response to UNAIDS HIV/AIDS Treatment Access Update
MSF welcomes promising HIV vaccine trial with cautious optimism
MSF Malawi study: Universal access to HIV treatement under threat from high drug prices
IAS 2009: MSF satellite session at Cape Town AIDS conference
Film on paediatric HIV/AIDS Mathare, Kenya
PMTCT Roundtable Presentations
The need to switch to improved drugs
Pushing to access AIDS drugs in China
PMTCT Expert Round Table Report
MSF Report Shows Up to 500 Percent Price Rise in HIV/AIDS drugs
Preventing the Consequences of Acute Malnutrition: A Challenge for MSF in Niger
Niger: Going Beyond the Crisis, an interview with Dr. Marie-Pierre Allié
Niger: Taking a Community Approach to Malnutrition
Interview with Dr. Benoit Kayembe in Chad on Malnutrition
WHA 2010: Infant and Young Child Nutrition
Natacha and the Hunger Gap in Burkina Faso
Alexis' Story: Battling Endemic Malnutrition in Burkina Faso
UNITAID gives green light to patent pool
How much is actually being spent on neglected disease research?
The U.S. FDA Priority Review Voucher
MSF Statement at the close of the 61st World Health Assembly
Mexico IAS satellite: Taking the Plunge
Germany's poor funding of neglected diseases
Médecins Sans Frontières statement at the close of UN health R&D summit
Comments by MSF on GSK and Pfizer signing supply agreements within GAVI's AMC
Advance Market Commitment: What is an AMC ?
How do Advance Market Commitments work ?
Concerns surrounding the use of AMCs
Development Today articles on Pneumococcal AMC
IGWG booklet: Alternative mechanisms
IGWG negotiations resume April 2008
IGWG booklet: Calling All Governments
IGWG booklet: Dying For a Test
IGWG booklet: And the Winner is.....
IGWG booklet: Is AIDS a Neglected Disease?
IGWG booklet: Advance Market Commitment
World Health Assembly May 2008
Wanted: Big Ideas for New Drugs
Alternative models: Paul Herrling interview
The Prize Fund Model: Interview with KEI's James Love
IGWG booklet: DNDi Public funding is not enough, public leadership is also needed
MSF welcomes the introduction of a new open-source user-friendly drug combination against malaria
MSF IGWG Recommendations to the European Commission
UN health talks could lead to new ways of developing urgently needed drugs and diagnostics
A Patent Free Drug for Malaria
MSF welcomes the introduction of a new open-source user-friendly drug combination against malaria
The Drugs for Neglected Diseases initiative
MSF Response to NIAID Request for Information on TB
Diagnosing children with TB: A terrible neglect
MSF sends letters to Ministers of Health on Antibiotic Resistance
MSF at 40th Union World Conference on Lung Health
Intervention by Médecins Sans Frontières on tuberculosis at World Health Assembly 2009
TB diagnostics meeting March 2009
TB funding report launch agenda
Give us the tools to meet the challenge
MSF TB Research Funding Report: November 08
Drug-Resistant TB: Give us the tools to meet the challenge
TB 'Die-In' in front of German parliament
MSF symposium at Union Conference 2008
TB Diagnostics Expert Meeting April 2008
Conflict in Georgia threatens drug resistant TB treatment programmes
Championing Open Source Drugs: SciDev article on leading Indian geneticist
Overcoming the gaps in TB research. Do we need to rewrite the rules?
SciDev: Championing open source drugs
MSF Measles Intervention at 63rd World Health Assembly
Op-Ed: Obama administration needs to tackle neglected diseases
MSF Intervention at WHO on Global Measles Strategy
The Affordable Medicines Facility for malaria (AMFm)
Diagnosing and Preventing Malaria
MSF Top Ten Humanitarian Crises 2008
Film Clip - Kala Azar, A Forgotten Disease
Fighting kala azar in the Indian state of Bihar
63rd World Health Assembly: a step forward in the fight against Chagas
MSF & DNDi Briefing at 63rd WHA
Chagas: Time to Break the Silence
Sleeping sickness: is the end in sight?
MSF welcomes UNITAID patent pool endorsement
Need to fix food aid to tackle the crisis of malnutrition
Chagas disease not addressed by World Health Assembly - Neglected disease neglected once again
MSF and DNDi call for scale-up of R&D for neglected diseases
MSF halts efforts to open MDR TB project in China
MSF Response to the G-FINDER Report 2009
Kala Azar: Patients lack adequate diagnosis and drugs
UN Madrid Food Summit Could Miss Critical Target
JAMA study shows food supplements can significantly reduce rates of deadliest forms of malnutrition
'Top Ten' Humanitarian crises reveal growing insecurity, neglected health needs
Fractional Dose of Scarce Meningitis Vaccine May Be Effective in Outbreak Control
Nine out of ten children are denied live-saving HIV/AIDS treatment
WHO Experts Raise Antiquated Nutrition Standards –
Malaria: From good intentions to effective action
WHO meeting has potential to impact millions of malnourished children
Brazil rejects patent on an essential AIDS medicine
Children with HIV deserve fair treatment
Mind The Deadly Gaps: IAC 2008
G8 Must Take Action To Save Most Vulnerable in Food Crisis
MSF makes its research accessible to health workers in developing countries
Two-Year Process To Overhaul Health R&D System Reaches Critical Stage at UN summit
Food Aid Basket Missing Critical Ingredients - with dire consequences for children under two
People in Southeast Asia needlessly becoming blind due to a neglected virus
MSF response to Lancet series on Malnutrition
“Somalia has some of the worst health indicators in the world and TB is not an exception”
Niger: Nearly 400,000 children and adults vaccinated against meningitis with the support of MSF
A dramatic treatment success story from Manipur, India
Children suffer the consequences of poor TB infection control: Six-year old MDR TB patient
Lesotho: MSF Lay counsellor and TB/HIV patient Mahlomola Panyane
MSF Malawi study: Universal access to HIV treatment under threat from high drug prices
First MSF drug-resistant patients 'healed' in Georgia
Treating Kala Azar in Bihar, India
One pill when the sun rises and one when it sets
Maes story: Living with MDR TB in Cambodia
Access to Maternal-Infant Prevention and to Preventative Treatment Makes a Difference
HIV-TB Co-infection: They’re already sitting in our waiting rooms
If you can prick a finger, you can test for kala azar
Kala Azar: A neglected disease
Confronting HIV-TB Co-infection in Lesotho
Ethiopian Food Crisis: Children's Stories
“Life is a daily struggle but for many people this year that struggle became too much to bear”
Drug Resistant TB in Cambodia: Catalyst for Change
The Hospital on the Edge of Town: MDR Treatment in Uzbekistan
Community workers tackle malaria in Sierra Leone
Treating drug resistant TB in Uzbekistan: Audio interview
Listen to Busisiwe Beko's story of living with MDR TB
CMV: A view from the field by Dr David Wilson
Positive Voice: How sharing experiences improves treatment and gives hope
Saving patients' vision in China
Busi's Story Living with drug resistant TB
Living with TB and HIV in Thyolo (Malawi)
Living with TB: Victor in Thyolo
Mosala's Story: Treating Drug-resistant TB in Lesotho
Monica's Two Daily Struggles: Fighting Resistant Tuberculosis and HIV/AIDS in Kenya's Mathare Slum
Dr. Pheello Lethola Talks about the challenges she faces in her work
Letter to The Guardian during the UN food summit
The Guardian Weekly: To fight Aids, drugs are not enough
SAM inadequately addressed in the Lancet Undernutrition Series
The Lancet: Correspondence on Undernutrition series
Reuters: WHO bridges rich-poor intellectual property split
Financial Times: WHO agrees drugs strategy to aid poor
IPS News: US choke point for US
Development Today: Secrecy surrounds billion-dollar aid deal for drug industry
Development Today: Donors want more facts before finalising 1.5b USD deal for vaccine industry
Development Today: USD 1.5 billion aims to boost supply of new vaccine
IPW: WHO members inch towards consenses on IP, Innovation and Public Health
IPW: WHO IP And Health Group Concludes With Progress; Tough Issues Remain For
Africa Science News: Mixed reaction as WHO's IP meet ends
Development Today: Editorial on Advance Market Commitment
The New York Times: Fighting Tuberculosis
MSF response to WSJ on Thailand compulsory licences
Campaign response to NYT article on MDR-TB report
BMJ MSF calls for use of ready-to-use food
DPA: New Approach needed for Drug-Resistant TB
AfricaScienceNews.org: Call for Increased Efforts on TB drug research
|
 |
|
 |
